Skip to main content
Drug bottle and Pill

Compare Tremfya vs. Taltz

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Tremfya (guselkumab) and Taltz (ixekizumab) are both monoclonal antibody medications used to treat moderate-to-severe plaque psoriasis and psoriatic arthritis. However, they belong to different classes of interleukin antagonists. Tremfya targets interleukin-23 (IL-23), while Taltz targets interleukin-17 (IL-17). Tremfya is also used for ulcerative colitis and Crohn's disease, while Taltz is approved for additional conditions like ankylosing spondylitis and non-radiographic axial spondyloarthritis. Tremfya is typically injected every 8 weeks after initial doses, whereas Taltz is injected every 4 weeks after the starting doses. Both medications are only available as brand-name options. Common side effects for both include upper respiratory infections and injection site reactions. Both medications can increase the risk of infections due to their effects on the immune system, and you should avoid live vaccines while using them.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.